Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes

Wendy A Hunter1, Tim Cundy, Diana Rabone

  • 1Liggins Institute, Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand. w.hunter@auckland.ac.nz

Diabetes Care
|April 28, 2004
PubMed

Insights

Children born to mothers with type 2 diabetes showed higher BMI and fat mass, with a trend toward lower insulin sensitivity (Si). Prenatal hyperglycemia alone did not alter glucose regulation in prepubertal offspring.

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Pediatric Health

Background:

  • Maternal diabetes can impact offspring metabolic health.
  • Understanding intrauterine effects on pediatric glucose regulation is crucial.

Purpose of the Study:

  • To investigate insulin sensitivity in prepubertal children exposed to diabetic intrauterine environments.
  • To differentiate effects of maternal type 1 vs. type 2 diabetes.

Main Methods:

  • Frequently sampled intravenous glucose tolerance test (FSIGT) in children aged 5-10.
  • Applied Bergman's minimal model to assess insulin sensitivity (Si), acute insulin response (AIR), and glucose effectiveness (Sg).
  • Measured BMI and body composition (bioelectrical impedance).

Main Results:

  • Offspring of mothers with type 2 diabetes had higher BMI SD scores and body fat percentage.
  • A trend towards lower insulin sensitivity (Si) and higher acute insulin response (AIR) was observed in offspring of type 2 diabetic mothers, though not statistically significant.
  • Offspring insulin sensitivity negatively correlated with BMI SD score, body fat percentage, and maternal insulin dose.

Conclusions:

  • Intrauterine hyperglycemia alone did not appear to alter glucose regulation in prepubertal offspring.
  • Children of mothers with type 2 diabetes were overweight and showed a tendency for reduced insulin sensitivity.
  • Genetic and postnatal factors, not solely prenatal hyperglycemia, may increase risk for impaired glucose tolerance in these children.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.